ArticleOncology letters2022

Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms.

Li Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.